Lymphopenia in Patients with Single-ventricle Heart Disease after the Fontan Operation

Monica Mattes1, Jason Connor1,2, Susan S Kelly3

  • 1College of Medicine, University of Central Florida, Orlando, Fla, USA.

Congenital Heart Disease
|November 12, 2015
PubMed

Insights

Lymphopenia is common in Fontan circulation patients without protein-losing enteropathy. Low lymphocyte counts were associated with low platelet counts, suggesting hepatic fibrosis may be a cause.

Area of Science:

  • Cardiology
  • Immunology
  • Pediatric Medicine

Background:

  • Lymphopenia is frequently observed in patients with Fontan circulation.
  • This phenomenon is often seen in patients without a history of protein-losing enteropathy (PLE).
  • The literature lacks detailed descriptions of lymphopenia in this specific patient group.

Purpose of the Study:

  • To investigate the prevalence of lymphopenia in patients with Fontan circulation.
  • To explore potential associations between patient characteristics and absolute lymphocyte count (ALC).
  • To identify underlying mechanisms for lymphopenia in this population.

Main Methods:

  • Retrospective analysis of patients with Fontan circulation undergoing catheterization.
  • Inclusion criteria: complete blood count (CBC) within 12 months of catheterization.
  • Exclusion criteria: infection, history of protein-losing enteropathy (PLE).
  • Examination of associations between patient characteristics and ALC.

Main Results:

  • Fifteen patients were included in the study.
  • A significant proportion of patients (26.7% to 46.7%) exhibited lymphopenia (ALC ≤ lower limit of normal).
  • Absolute lymphocyte count (ALC) showed positive associations with platelet count and total white blood cell count.

Conclusions:

  • Lymphopenia is a common finding in Fontan circulation patients without PLE.
  • A positive association between lymphopenia and low platelet count was observed.
  • Hepatic fibrosis, previously linked to thrombocytopenia in Fontan patients, may also underlie lymphopenia.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.3K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
637
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
873
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
568
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
377